Investitionsthese
Lynx Financial connects life science innovators across China, the U.S., and Europe with capital and strategic partners, leveraging a team of physicians, scientists, and investors to accelerate medical technologies to patients globally.
Investitionsphase
Seed to Series A (equity investment) + cross-border advisory (inbound/outbound).
Bevorzugte Reifephase für die erste Finanzierung.
Sektoren & Themen
Cross-border healthcare innovation (pharma, diagnostics, medical devices) with a focus on oncology, cardiovascular, rare diseases, pre-operative cancer diagnostics, medical devices (e.g., valves, implants), and global R&D acceleration.
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Ticketgröße
k.A.
Standard-Finanzierungsbetrag pro Runde.
Outreach & Dossier-Analysen
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
